Learn more

PRO NEURON INC

Overview
  • Total Patents
    192
About

PRO NEURON INC has a total of 192 patent applications. Its first patent ever was published in 1988. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are PHARMAESSENTIA CORP, IMMUNE SYSTEM REGULATION HOLDING AB and TRUOG PETER.

Patent filings per year

Chart showing PRO NEURON INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Bamat Michael Kevin 57
#2 Bamat Michael K 49
#3 Von Borstel Reid W 34
#4 Hiltbrand Bradley M 33
#5 Tsyrlova Irena 30
#6 Borstel Reid Warren Von 28
#7 Von Borstel Reid Warren 26
#8 Wolpe Stephen D 21
#9 Kozlov Vladimir 19
#10 Shirali Shyam 15

Latest patents

Publication Filing date Title
AU2006236108A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
AU2005232281A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
AU2002313992B2 Compositions and Methods for Treatment of Mitochondrial Diseases
AU2491301A Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
NZ504512A Peptide from alpha-hemoglobin as a stimulator of stem cell proliferation and used thereof
AU5262499A Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
CN1285751A Antimutagenic compositions for treatment and prevention of photodamage to skin
US6472378B2 Compositions and methods for treatment of mitochondrial diseases
ZA9802746B Inhibitor and stimulator of stem cell proliferation and uses thereof
MX9709749A Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides.
KR20000005428A Inhibitor and stimulator of proliferating of liver cell, and their use
IL159708D0 Peptides and their use in manufacturing medicaments and in identifying receptors.
US6218519B1 Compounds and methods for the selective treatment of cancer and bacterial infections
US5861483A Inhibitor of stem cell proliferation and uses thereof
UA54379C2 Stem cell inhibiting factors, pharmaceutical composition (variants) and methods for their use (variants)
US5939391A Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
WO9604923A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides
CN1156409A Pyrimidine nucleotide precursors for treating of systemic inflammation and inflammatory hepatitis
AU2915095A Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
US6348451B1 Acyl deoxyribonucleoside derivatives and uses thereof